Skip to main content
. 2019 Jun;31(2):84–87. doi: 10.5455/msm.2019.31.84-87

Table 2. Pharmacological modalities.

Medications at discharge or lethal outcome N %
OAK (Acenocoumarol, Warfarin) 677 53.47
DOAK (Rivaroxaban, Apixaban, Dabigatran) 203 17.59
LMWH (Enoxaparin Na, Reviparin Na, Fondaparinux) 224 19,41
UF heparin 4 0.35
Other drugs (Acetylsalicylicacid, clopidogrel, dipiridamol) 6 0.52
Lethal outcome 40 3.47
Total 1154 100,00